Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes. Farngren J, Ahren B. Metabolism 2019;99:25-31.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Farngren J, Ahren B. Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes. Metabolism 2019;99:25-31.
PMID: 31279738